Yan Liang

2.3k total citations
95 papers, 1.4k citations indexed

About

Yan Liang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Yan Liang has authored 95 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 22 papers in Cardiology and Cardiovascular Medicine and 20 papers in Oncology. Recurrent topics in Yan Liang's work include Cancer-related molecular mechanisms research (12 papers), Cardiovascular Effects of Exercise (8 papers) and MicroRNA in disease regulation (7 papers). Yan Liang is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), Cardiovascular Effects of Exercise (8 papers) and MicroRNA in disease regulation (7 papers). Yan Liang collaborates with scholars based in China, United States and Hong Kong. Yan Liang's co-authors include Gen‐Sheng Feng, Farah Sheikh, Gang Wang, Yao Xiao, Junxian Zhang, Jingwen Yin, Xueqiong Wu, Kota Kaneko, William H. Bradford and Yan Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Yan Liang

86 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Liang China 24 704 265 245 229 166 95 1.4k
Rui Zhu China 22 484 0.7× 156 0.6× 156 0.6× 150 0.7× 67 0.4× 63 1.2k
Hanning You United States 14 494 0.7× 189 0.7× 159 0.6× 282 1.2× 56 0.3× 18 1.1k
Pengbo Wang China 15 720 1.0× 120 0.5× 130 0.5× 319 1.4× 72 0.4× 51 1.3k
Naoya Mimura Japan 23 901 1.3× 207 0.8× 102 0.4× 366 1.6× 67 0.4× 84 1.8k
Daryl M. Okamura United States 19 521 0.7× 261 1.0× 132 0.5× 122 0.5× 85 0.5× 34 1.4k
Xiaoyun Cheng China 21 572 0.8× 300 1.1× 198 0.8× 590 2.6× 58 0.3× 78 1.6k
Pierre Scotney Australia 15 553 0.8× 157 0.6× 107 0.4× 168 0.7× 123 0.7× 21 1.0k
Xiaoxi Lv China 23 897 1.3× 276 1.0× 296 1.2× 298 1.3× 58 0.3× 43 1.7k

Countries citing papers authored by Yan Liang

Since Specialization
Citations

This map shows the geographic impact of Yan Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Liang more than expected).

Fields of papers citing papers by Yan Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Liang. The network helps show where Yan Liang may publish in the future.

Co-authorship network of co-authors of Yan Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Liang. A scholar is included among the top collaborators of Yan Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Liang. Yan Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gu, Xin, Zhixuan Zhang, Lin Zhao, et al.. (2025). Exposure to polyethylene terephthalate micro(nano)plastics exacerbates inflammation and fibrosis after myocardial infarction by reprogramming the gut and lung microbiota and metabolome. Journal of Hazardous Materials. 488. 137410–137410. 9 indexed citations
3.
Lv, Xiaokang, et al.. (2025). The Emerging Role of Citrulline and Theanine in Health and Disease: A Comprehensive Review. Nutrients. 17(21). 3496–3496.
4.
Qin, Ge, Guolin He, Mingyu Liang, et al.. (2025). Evaluation of first‐trimester ultrasound screening strategy for fetal congenital heart disease. Ultrasound in Obstetrics and Gynecology. 65(4). 478–486.
5.
6.
Zhang, Meiling, Ning Xie, Chunxia Wu, et al.. (2025). Novel nanoparticle-combined therapy through EGFR and PD-L1 blockade: PFPR-siRNA-mediated suppressing NSCLC proliferation via PDT and enhanced antitumor immunity. Colloids and Surfaces B Biointerfaces. 259. 115284–115284.
7.
Wang, Jingxian, Yan Liang, Jingyu Liu, et al.. (2025). Effect of PCSK9 inhibitors on the quality of life in patients with acute coronary syndromes — exploratory analysis of the EMSIACS trial. Scientific Reports. 15(1). 42493–42493.
8.
Huang, Xiang, Nan Jin, Chunxiao Sun, et al.. (2024). Abstract PO1-04-04: Inetetamab combined with pyrotinib and oral vinorelbine for patients with HER2-positive metastatic breast cancer: a single-arm phase 2 trial. Cancer Research. 84(9_Supplement). PO1–4. 1 indexed citations
9.
Liang, Yan, et al.. (2023). Ononin alleviates DSS‐induced colitis through inhibiting NLRP3 inflammasome via triggering mitophagy. Immunity Inflammation and Disease. 11(2). e776–e776. 23 indexed citations
10.
Kaneko, Kota, Yan Liang, Qing Liu, et al.. (2023). Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit. eLife. 12. 2 indexed citations
11.
Schinner, Camilla, Lifen Xu, Henriette Franz, et al.. (2022). Defective Desmosomal Adhesion Causes Arrhythmogenic Cardiomyopathy by Involving an Integrin-αVβ6/TGF-β Signaling Cascade. Circulation. 146(21). 1610–1626. 28 indexed citations
12.
Yang, Jia, Yu Li, Chuanyin Li, et al.. (2022). The Association of TNF-α Promoter Polymorphisms with Genetic Susceptibility to Cervical Cancer in a Chinese Han Population. Dove Medical Press (Taylor and Francis Group). 6 indexed citations
13.
Shi, Hai, Tianyu Zeng, Fan Yang, et al.. (2022). Assembly of Nanocatalyst As a Noninvasive Tool for Breast Cancer Diagnosis and Immunotherapy Surveillance Designed by Visually Tracking Tumor-Derived Exosomal PD-L1. ACS Materials Letters. 5(2). 282–290. 4 indexed citations
14.
Chen, Wendy S., et al.. (2021). Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment. Cell Reports. 37(6). 109974–109974. 35 indexed citations
15.
Zhang, Jing, Yan Liang, William H. Bradford, & Farah Sheikh. (2021). Desmosomes: emerging pathways and non-canonical functions in cardiac arrhythmias and disease. Biophysical Reviews. 13(5). 697–706. 12 indexed citations
16.
Liang, Yan, Hesheng Luo, Haidong Zhang, Youhong Dong, & Ying Bao. (2018). Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis. Cancer Biotherapy and Radiopharmaceuticals. 33(9). 380–386. 9 indexed citations
17.
Zhang, Xuxin, Yanzhao Li, Yan Liang, et al.. (2017). Distinguishing Intracerebral Hemorrhage from Acute Cerebral Infarction through Metabolomics. Revista de investigaci�n Cl�nica. 69(6). 319–328. 27 indexed citations
18.
Liang, Yan, Robert C. Lyon, Jason Pellman, et al.. (2016). Abstract 20108: A Newly Identified Interaction Between Desmoplakin and COP9 Signalsome Subunit 6 Reveals a New Mechanism Underlying Sudden Death. Circulation. 134. 1 indexed citations
19.
Xiao, Yao, Zhanyun Tang, Xing Fu, et al.. (2015). The M ediator subunit MED 23 couples H2B mono‐ubiquitination to transcriptional control and cell fate determination. The EMBO Journal. 34(23). 2885–2902. 31 indexed citations
20.
Liu, Zhenghui, Yuanlin Ding, Haiyan Pan, et al.. (2013). A Meta-Analysis of the Association between TNF-α −308G>A Polymorphism and Type 2 Diabetes Mellitus in Han Chinese Population. PLoS ONE. 8(3). e59421–e59421. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rui Zhu Breakdown of academic impact, for papers by Hanning You Breakdown of academic impact, for papers by Pengbo Wang Breakdown of academic impact, for papers by Naoya Mimura Breakdown of academic impact, for papers by Daryl M. Okamura Breakdown of academic impact, for papers by Xiaoyun Cheng Breakdown of academic impact, for papers by Pierre Scotney Breakdown of academic impact, for papers by Xiaoxi Lv
Rankless by CCL
2026